Added to YB: 2024-11-04
Pitch date: 2024-11-02
NSIS-B.CO [bullish]
Novonesis A/S
-7.06%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally.
Market Cap
DKK 26.9B
Pitch Price
DKK 425.42
Price Target
518.52 (+31%)
Dividend
0.93%
EV/EBITDA
36.65
P/E
56.81
EV/Sales
9.41
Sector
Chemicals
Category
growth
Novonesis 🇩🇰 A Biosolutions Leader with Strong Growth Potential
NSIS-B.CO: World leader in biosolutions post-merger. 10% Q2 organic growth. 7-8% FY guidance. Strong R&D, emerging markets presence. Human health, protein solutions key growth drivers. €20B market, €1T potential. Risks: pricing power, commodity dependence. 20% upside in 12-18 months.
Read full article (3 min)